Author: Kovacevic, Pedja; Tomic, Boris; Kovacevic, Tijana; Dragic, Sasa
Title: Use of CytoSorb® as a therapeutic option in a critically ill patient with acute respiratory distress syndrome caused by influenza A (H1N1) pneumonia: A case report Cord-id: mm8n2in0 Document date: 2020_12_29
ID: mm8n2in0
Snippet: Acute respiratory distress syndrome is an acute inflammatory lung process, which leads to protein-rich nonhydrostatic pulmonary edema, refractory hypoxemia, and lung “stiffnessâ€. There are a number of therapies that are currently being investigated in the treatment of sepsis; one of the most promising treatment options at this moment is cytokine removal by hemoperfusion (CytoSorb(®)). We present the case of a 29-year-old male patient who was admitted to the Medical Intensive Care Unit in a
Document: Acute respiratory distress syndrome is an acute inflammatory lung process, which leads to protein-rich nonhydrostatic pulmonary edema, refractory hypoxemia, and lung “stiffnessâ€. There are a number of therapies that are currently being investigated in the treatment of sepsis; one of the most promising treatment options at this moment is cytokine removal by hemoperfusion (CytoSorb(®)). We present the case of a 29-year-old male patient who was admitted to the Medical Intensive Care Unit in a state of multiple organ dysfunction and massive bilateral pneumonia caused by influenza type A. The patient was healthy before hospital admission. Due to acute respiratory failure and altered state of consciousness, the patient was intubated using analgosedation and connected to a controlled mechanical ventilation mode immediately after admission. The initial computed tomography scan showed massive bilateral pneumonia, and few days later, the patient's condition progressively worsened and he developed signs of multiorgan failure. Given the patient's progressing hemodynamic instability and uncontrolled inflammatory response, a CytoSorb(®) adsorber was added into the continuous renal replacement therapy circuit. The combination of pharmacotherapy, supportive measures, and application of CytoSorb(®) resulted with complete recovery of the patient (hemodynamic stability improved as evidenced by decreased vasopressor requirements).
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and lung ability: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung edema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung process: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and lung protective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung protective ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung refractory hypoxemia: 1, 2
- acute onset and liver dysfunction: 1, 2, 3
- acute onset and lung edema: 1, 2, 3, 4, 5
- acute onset and lung function: 1, 2, 3, 4, 5, 6, 7, 8
- acute onset and lung process: 1, 2, 3
- acute onset and lung protective: 1, 2, 3, 4, 5
- acute onset and lung protective ventilation: 1, 2, 3, 4, 5
- acute renal failure and liver dysfunction: 1, 2, 3
- acute renal failure and lung function: 1, 2
- acute renal failure and lung protective: 1
- acute renal failure and lung protective ventilation: 1
- liver dysfunction and lung function: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date